Aug 2026
Management of Aggressive PitNETs: Evidence Gaps, Molecular Clues, and a Roadmap for Clinical Trials.
Progress will rely on harmonizing diagnostic criteria, integrating molecular and imaging biomarkers, and embedding translational endpoints into clinical trials to define a path toward more precise recognition and management of aggressive pituitary tumors.
R. L. Batista, F. Castinetti, Luciana Ansaneli Naves
· Endocrine-Related Cancer · 0 citations